Drug discovery can be a long and complex process. Medicines for neurodegenerative diseases like Alzheimer's disease are among the most expensive to develop, as animal model results have not proven to ...

This infographic explores key analytical technologies used in high-throughput drug discovery, highlighting their strengths, ...

At Pharmaron, precision drives everything we do. To ensure consistent, high-quality results, we use the Explorer G3 integrated workstation to fully automate our drug screening workflows for both ...

The South Korea automated liquid handling system market is poised for significant growth, expanding from $23.5 million in ...

A new study published in Cell has unveiled a first-of-a-kind optogenetic screening platform, developed by scientists at Integrated Biosciences, a biotechnology company integrating optogenetics, ...

The novel kit leverages advanced cell-free protein synthesis technology to enable rapid, efficient in vitro production of target proteins and antibodies—eliminating the constraints of traditional cell ...

Researchers at the Purdue Institute for Cancer Research (PICR) have developed a next-generation technology platform designed to accelerate one of the slowest and most challenging stages of cancer drug ...

A novel optogenetic screening platform enables control over previously intractable biological systems. Using the screening platform, scientists have been able to selectively activate the integrated ...

The "Drug Discovery Technologies Market by Product, Technology, Process, Therapeutic Area - Global Forecast to 2030" has been added to ResearchAndMarkets.com's offering. The drug discovery ...

Revvity offers comprehensive solutions designed to help accelerate laboratory workflows, assisting researchers meet targets faster and bring new therapies to market sooner. Our integrated approach ...